全文获取类型
收费全文 | 25923篇 |
免费 | 2087篇 |
国内免费 | 1076篇 |
出版年
2024年 | 32篇 |
2023年 | 225篇 |
2022年 | 558篇 |
2021年 | 1077篇 |
2020年 | 691篇 |
2019年 | 835篇 |
2018年 | 986篇 |
2017年 | 676篇 |
2016年 | 1064篇 |
2015年 | 1497篇 |
2014年 | 1704篇 |
2013年 | 1922篇 |
2012年 | 2360篇 |
2011年 | 2071篇 |
2010年 | 1287篇 |
2009年 | 1093篇 |
2008年 | 1466篇 |
2007年 | 1316篇 |
2006年 | 1134篇 |
2005年 | 1055篇 |
2004年 | 893篇 |
2003年 | 750篇 |
2002年 | 684篇 |
2001年 | 558篇 |
2000年 | 438篇 |
1999年 | 401篇 |
1998年 | 231篇 |
1997年 | 174篇 |
1996年 | 151篇 |
1995年 | 148篇 |
1994年 | 112篇 |
1993年 | 93篇 |
1992年 | 155篇 |
1991年 | 139篇 |
1990年 | 132篇 |
1989年 | 105篇 |
1988年 | 90篇 |
1987年 | 91篇 |
1986年 | 66篇 |
1985年 | 68篇 |
1984年 | 43篇 |
1983年 | 42篇 |
1982年 | 42篇 |
1981年 | 36篇 |
1979年 | 47篇 |
1978年 | 40篇 |
1977年 | 42篇 |
1976年 | 36篇 |
1975年 | 27篇 |
1974年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
991.
QKI‐6 inhibits bladder cancer malignant behaviours through down‐regulating E2F3 and NF‐κB signalling
992.
993.
Yu‐Han Wang Xiao‐Hui Huang Yan‐Mei Yang Youdi He Xiao‐Hui Dong Hui‐Xin Yang Lei Zhang Yan Wang Jin Zhou Changyong Wang Xiao‐Xia Jiang 《Journal of cellular and molecular medicine》2019,23(5):3737-3746
Adipose‐derived stem cells (ASCs) are highly attractive for cell‐based therapies in tissue repair and regeneration because they have multilineage differentiation capacity and are immunosuppressive. However, the detailed epigenetic mechanisms of their immunoregulatory capacity are not fully defined. In this study, we found that Mysm1 was induced in ASCs treated with inflammatory cytokines. Adipose‐derived stem cells with Mysm1 knockdown exhibited attenuated immunosuppressive capacity, evidenced by less inhibition of T cell proliferation, more pro‐inflammatory factor secretion and less nitric oxide (NO) production in vitro. Mysm1‐deficient ASCs exacerbated inflammatory bowel diseases but inhibited tumour growth in vivo. Mysm1‐deficient ASCs also showed depressed miR‐150 expression. When transduced with Mysm1 overexpression lentivirus, ASCs exhibited enhanced miR‐150 expression. Furthermore, Mysm1‐deficient cells transduced with lentivirus containing miR‐150 mimics produced less pro‐inflammatory factors and more NO. Our study reveals a new role of Mysm1 in regulating the immunomodulatory activities of ASCs by targeting miR‐150. These novel insights into the mechanisms through which ASCs regulate immune reactions may lead to better clinical utility of these cells. 相似文献
994.
995.
Yunkai Wang Yajun Hong Chunyu Zhang Yunli Shen Ye Shen Pan Rui Zhen Chen Qi Zhang Yi Han Chen 《Journal of cellular and molecular medicine》2019,23(1):464-475
Picroside II (P‐II), one of the main active components of scrophularia extract, which have anti‐oxidative, anti‐inflammatory effects, but its effect on hyperhomocysteinemia (HHcy) induced endothelial injury remains to be determined. Here, we test whether P‐II protects HHcy‐induced endothelial dysfunction against oxidative stress, inflammation and cell apoptosis. In vitro study using HUVECs, and in hyperhomocysteinemia mouse models, we found that HHcy decreased endothelial SIRT1 expression and increased LOX‐1 expression, subsequently causing reactive oxygen species generation, up‐regulation of NADPH oxidase activity and NF‐κB activation, thereby promoting pro‐inflammatory response and cell apoptosis. Blockade of Sirt1 with Ex527 or siRNASIRT1 increased LOX‐1 expression, whereas overexpression of SIRT1 decreased LOX‐1 expression markedly. P‐II treatment significantly increased SIRT1 expression and reduced LOX‐1 expression, and protected against endothelial cells from Hcy‐induced oxidative injury, inflammation and apoptosis. However, blockade of SIRT1 or overexpression of LOX‐1 attenuated the therapeutic effects of P‐II. In conclusion, our results suggest that P‐II prevents the Hcy induced endothelial damage probably through regulating the SIRT1/LOX‐1 signaling pathway. 相似文献
996.
Bo Wang Deliang Shen Junnan Tang Jing Li Yue Xiao Xiuying Chen Chang Cao Dongjian Han Erhe Gao Wen Zhao Jinying Zhang Junbiao Chang 《Journal of cellular and molecular medicine》2019,23(9):6048-6059
Sodium (±)‐5‐bromo‐2‐(a‐hydroxypentyl) benzoate (generic name: brozopine, BZP) has been reported to protect against stroke‐induced brain injury and was approved for Phase II clinical trials for treatment of stroke‐related brain damage by the China Food and Drug Administration (CFDA). However, the role of BZP in cardiac diseases, especially in pressure overload‐induced cardiac hypertrophy and heart failure, remains to be investigated. In the present study, angiotensin II stimulation and transverse aortic constriction were employed to induce cardiomyocyte hypertrophy in vitro and in vivo, respectively, prior to the assessment of myocardial cell autophagy. We observed that BZP administration ameliorated cardiomyocyte hypertrophy and excessive autophagic activity. Further results indicated that AMP‐activated protein kinase (AMPK)‐mediated activation of the mammalian target of rapamycin (mTOR) pathway likely played a role in regulation of autophagy by BZP after Ang II stimulation. The activation of AMPK with metformin reversed the BZP‐induced suppression of autophagy. Finally, for the first time, we demonstrated that BZP could protect the heart from pressure overload‐induced hypertrophy and dysfunction, and this effect is associated with its inhibition of maladaptive cardiomyocyte autophagy through the AMPK‐mTOR signalling pathway. These findings indicated that BZP may serve as a promising compound for treatment of pressure overload‐induced cardiac remodelling and heart failure. 相似文献
997.
998.
Kyoungjune Pak Yun Hak Kim Sunghwan Suh Tae Sik Goh Dae Cheon Jeong Seong Jang Kim In Joo Kim Myoung‐Eun Han Sae‐Ock Oh 《Journal of cellular and molecular medicine》2019,23(4):3010-3015
As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC) increases, accurate risk stratification is required. To develop a novel prognostic scoring system for patients with PTC (n = 455), we used mRNA expression and clinical data from The Cancer Genome Atlas. We performed variable selection using Network‐Regularized high‐dimensional Cox‐regression with gene network from pathway databases. The risk score was calculated using a linear combination of regression coefficients and mRNA expressions. The risk score and clinical variables were assessed by several survival analyses. The risk score showed high discriminatory power for the prediction of event‐free survival as well as the presence of metastasis. In multivariate analysis, the risk score and presence of metastasis were significant risk factors among the clinical variables that were examined together. In the current study, we developed a risk scoring system that will help to identify suitable therapeutic options for PTC. 相似文献
999.
1000.